This collaboration marks a significant stride in biotechnological services, covering major geographical regions including China, Singapore, Thailand, Malaysia, Indonesia, Vietnam, Philippines, Japan, and South Korea. Sino Biological, with its headquarters in Beijing, China, has established itself as a global leader in the supply of mammalian cell-based recombinant proteins and antibodies, as well as an array of contract research services. A key segment of its service portfolio includes the custom design, development, and manufacturing of monoclonal antibodies for research and in vitro diagnostics applications.

The synergistic integration of Rapid Novor’s proprietary REmAb technology for monoclonal antibody sequencing with Sino Biological’s custom mAb development services is set to offer clients unparalleled insights into antibody structure and functionality. This will significantly empower clients to refine antibody engineering processes, safeguard intellectual property rights, and accelerate the development of novel diagnostic tools and drug discovery endeavors.

Dr. Rob Burgess, Chief Business Officer at Sino Biological, expressed his enthusiasm for the partnership, stating, “Rapid Novor’s REmAb monoclonal antibody sequencing capabilities perfectly complement Sino Biological’s antibody development and manufacturing services. We believe the combination of these services synergistically elevates the value of our custom monoclonal antibody products for our clients.”

Echoing this sentiment, Iain Rogers, VP Commercial at Rapid Novor, remarked on the integration of the two companies’ services, “An integrated solution combining reliable protein sequencing and recombinant expression gives scientists a convenient way to fully understand and produce useful antibodies. We are excited that Sino Biological’s clients will now have access to accurate sequencing via our REmAb technology.”

This collaboration between Sino Biological and Rapid Novor stands as a testament to the ongoing commitment of both companies to advancing scientific research and development through innovative and high-quality services.